Apixaban outperforms warfarin regardless of prior stroke, TIA, or TE
31 Mar 2020
bởiElvira Manzano
Apixaban
outperformed warfarin in preventing ischaemic events regardless of prior stroke,
transient ischaemic attack (TIA), or thromboembolic event (TE) in patients with
atrial fibrillation (AF) with recent acute coronary syndrome (ACS) or percutaneous
coronary intervention (PCI), a
prespecified secondary analysis of the AUGUSTUS trial has shown.
Apixaban outperforms warfarin regardless of prior stroke, TIA, or TE
31 Mar 2020